Published in Tuberculosis (Edinb) on September 15, 2010
Consequences of genomic diversity in Mycobacterium tuberculosis. Semin Immunol (2014) 1.30
Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS One (2011) 1.22
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology. Am J Pathol (2011) 1.19
Mycobacterium tuberculosis strains of the modern sublineage of the Beijing family are more likely to display increased virulence than strains of the ancient sublineage. J Clin Microbiol (2014) 1.18
Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus). Infect Immun (2013) 1.16
Increased Foxp3 expression in guinea pigs infected with W-Beijing strains of M. tuberculosis. Tuberculosis (Edinb) (2011) 1.09
Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis. PLoS Pathog (2014) 0.98
Modulation of cell death by M. tuberculosis as a strategy for pathogen survival. Clin Dev Immunol (2011) 0.92
Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991-2007. Emerg Infect Dis (2013) 0.89
Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response. PLoS One (2013) 0.88
The pattern of cytokine production in vitro induced by ancient and modern Beijing Mycobacterium tuberculosis strains. PLoS One (2014) 0.88
A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics. Clin Microbiol Rev (2015) 0.86
Persistent Infection by a Mycobacterium tuberculosis Strain That Was Theorized To Have Advantageous Properties, as It Was Responsible for a Massive Outbreak. J Clin Microbiol (2015) 0.83
Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens. Front Microbiol (2015) 0.81
Lipidomics and genomics of Mycobacterium tuberculosis reveal lineage-specific trends in mycolic acid biosynthesis. Microbiologyopen (2014) 0.80
Origins of a 350-kilobase genomic duplication in Mycobacterium tuberculosis and its impact on virulence. Infect Immun (2014) 0.80
Low dose aerosol fitness at the innate phase of murine infection better predicts virulence amongst clinical strains of Mycobacterium tuberculosis. PLoS One (2012) 0.80
Field-isolated genotypes of Mycobacterium bovis vary in virulence and influence case pathology but do not affect outbreak size. PLoS One (2013) 0.79
RNAseq reveals hypervirulence-specific host responses to M. tuberculosis infection. Virulence (2016) 0.79
Genetic diversity of Mycobacterium tuberculosis from Guadalajara, Mexico and identification of a rare multidrug resistant Beijing genotype. PLoS One (2015) 0.76
Secretome Prediction of Two M. tuberculosis Clinical Isolates Reveals Their High Antigenic Density and Potential Drug Targets. Front Microbiol (2017) 0.75
Distribution and transmission of Mycobacterium tuberculosis complex lineages among children in peri-urban Kampala, Uganda. BMC Pediatr (2015) 0.75
Variation in C - reactive protein response according to host and mycobacterial characteristics in active tuberculosis. BMC Infect Dis (2016) 0.75
Characterisation of pks15/1 in clinical isolates of Mycobacterium tuberculosis from Mexico. Mem Inst Oswaldo Cruz (2013) 0.75
Trick or tween: An inflammatory surprise when M. tuberculosis knocks a cell's door and no tween is provided. Virulence (2016) 0.75
Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med (1999) 8.80
A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol (2003) 4.66
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis (2001) 4.01
Oligonucleotide (GTG)5 as a marker for Mycobacterium tuberculosis strain identification. J Clin Microbiol (1994) 3.41
Microevolution of the direct repeat region of Mycobacterium tuberculosis: implications for interpretation of spoligotyping data. J Clin Microbiol (2002) 3.12
Perceptual restoration of missing speech sounds. Science (1970) 3.08
A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol (2007) 2.83
Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis (2006) 2.78
Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference. Int J Tuberc Lung Dis (2006) 2.78
Purification of sputum samples through sucrose improves detection of Mycobacterium tuberculosis by polymerase chain reaction. J Clin Microbiol (1992) 2.53
Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Arch Dis Child (2005) 2.39
Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis (1999) 2.31
Receptor types in cat hairy skin supplied by myelinated fibers. J Neurophysiol (1968) 2.10
Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. Int J Tuberc Lung Dis (2010) 2.00
Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears. Antimicrob Agents Chemother (2007) 1.93
Mapping of IS6110 flanking regions in clinical isolates of Mycobacterium tuberculosis demonstrates genome plasticity. Mol Microbiol (2000) 1.92
Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today (1994) 1.90
Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children. Clin Infect Dis (2003) 1.88
Incidence of gonococci relatively resistant to penicillin occurring in the Southampton area of England during 1958 to 1965. Br J Vener Dis (1968) 1.87
Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin Exp Immunol (2004) 1.87
The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid. Clin Infect Dis (2004) 1.87
The burden of childhood tuberculosis: a public health perspective. Int J Tuberc Lung Dis (2005) 1.86
Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis (Edinb) (2008) 1.81
Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber Lung Dis (1999) 1.77
Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis. Am J Respir Crit Care Med (1997) 1.74
A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob Agents Chemother (2009) 1.74
Clonal expansion of a globally disseminated lineage of Mycobacterium tuberculosis with low IS6110 copy numbers. J Clin Microbiol (2004) 1.73
Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis. Allergy (2011) 1.73
The pathogenesis of tuberculosis. Annu Rev Microbiol (1996) 1.73
Spoligotype signatures in the Mycobacterium tuberculosis complex. J Clin Microbiol (2006) 1.71
The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay. J Clin Microbiol (2012) 1.70
Disruption of coding regions by IS6110 insertion in Mycobacterium tuberculosis. Tuber Lung Dis (1999) 1.67
Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents. Eur J Clin Microbiol Infect Dis (2010) 1.67
Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients. Int J Tuberc Lung Dis (2011) 1.67
Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis disease. J Clin Microbiol (2002) 1.62
Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis (2008) 1.62
Evolution of the IS6110-based restriction fragment length polymorphism pattern during the transmission of Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.55
Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis (2006) 1.53
Genotyping of Mycobacterium tuberculosis with additional markers enhances accuracy in epidemiological studies. J Clin Microbiol (1996) 1.51
Impact of social interactions in the community on the transmission of tuberculosis in a high incidence area. Thorax (1999) 1.50
Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. Magn Reson Imaging (2000) 1.47
Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa. Int J Tuberc Lung Dis (2012) 1.47
Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. J Clin Microbiol (2008) 1.46
Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis (2006) 1.46
Mycobacterium tuberculosis Beijing genotype: a template for success. Tuberculosis (Edinb) (2011) 1.44
Expression, characterization and subcellular localization of the Mycobacterium tuberculosis PPE gene Rv1917c. Tuberculosis (Edinb) (2001) 1.44
Evidence that the spread of Mycobacterium tuberculosis strains with the Beijing genotype is human population dependent. J Clin Microbiol (2007) 1.42
Demonstration of reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: multilesional genotyping of Mycobacterium tuberculosis utilizing IS 6110 and other repetitive element-based DNA fingerprinting. Tuberculosis (Edinb) (2001) 1.42
Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. J Clin Microbiol (2004) 1.36
Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int J Tuberc Lung Dis (2007) 1.33
Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int J Tuberc Lung Dis (2010) 1.32
Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission. Antimicrob Agents Chemother (2012) 1.31
Adult-to-child transmission of tuberculosis: household or community contact? Int J Tuberc Lung Dis (2003) 1.31
The mycosins of Mycobacterium tuberculosis H37Rv: a family of subtilisin-like serine proteases. Gene (2000) 1.31
Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res (1987) 1.30
Increasing the intelligibility of speech through multiple phonemic restorations. Percept Psychophys (1992) 1.26
Auditory induction: perceptual synthesis of absent sounds. Science (1972) 1.24
Molecular evolution of Mycobacterium tuberculosis: phylogenetic reconstruction of clonal expansion. Tuberculosis (Edinb) (2001) 1.24
Fine needle aspiration biopsy: an undervalued diagnostic modality in paediatric mycobacterial disease. Int J Tuberc Lung Dis (2009) 1.22
Novel method for rapid measurement of growth of mycobacteria in detergent-free media. J Clin Microbiol (1998) 1.20
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid. Eur J Clin Pharmacol (2007) 1.20
Sequence polymorphism in the rrs gene of Mycobacterium tuberculosis is deeply rooted within an evolutionary clade and is not associated with streptomycin resistance. J Clin Microbiol (2001) 1.17
inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? Int J Tuberc Lung Dis (2011) 1.17
How reliable is modern breast imaging in differentiating benign from malignant breast lesions in the symptomatic population? Clin Radiol (1999) 1.17
Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya. Int J Tuberc Lung Dis (2004) 1.14
An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. Int J Tuberc Lung Dis (2006) 1.14
Improved method for the routine identification of toxigenic Escherichia coli by DNA amplification of a conserved region of the heat-labile toxin A subunit. J Clin Microbiol (1991) 1.14
Predominance of a single genotype of Mycobacterium tuberculosis in regions of Southern Africa. Int J Tuberc Lung Dis (2007) 1.13
Fluorometric assay for testing rifampin susceptibility of Mycobacterium tuberculosis complex. J Clin Microbiol (2008) 1.13
Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing. Antimicrob Agents Chemother (2012) 1.12